Centessa Pharmaceuticals plc

Centessa Pharmaceuticals plcverified

CNTA

Price:

$39.72

Market Cap:

$6.15B

Centessa Pharmaceuticals plc operates as a clinical-stage pharmaceutical enterprise focused on discovering, developing, and ultimately providing therapeutic solutions to patients. The company's most advanced product candidates include Lixivaptan, a small molecule inhibitor of the vasopressin V2 receptor, which is currently undergoing Phase III clinical evaluation for treating autosomal dominant polycystic kidney disease. Additionally, SerpinPC, an activated protein C inhibitor, is progressing through Phase IIa clinical development for the management of hemophilia A and B. Centessa's pipeline also features several emerging assets in the clinical proof-of-concept stage. These comprise LB101 (a...[Read more]

Industry

Biotechnology

IPO Date

2021-05-28

Stock Exchange

NASDAQ

Ticker

CNTA

The ROE as of June 2026 (TTM) for Centessa Pharmaceuticals plc (CNTA) is -60.37%

According to Centessa Pharmaceuticals plc’s latest financial reports and current stock price. The company's current ROE is -60.37%. This represents a change of 291.91% compared to the average of -15.40% of the last 4 quarters.

Centessa Pharmaceuticals plc (CNTA) Historical ROE (quarterly & annually)

How has CNTA ROE performed in the past?

The mean historical ROE of Centessa Pharmaceuticals plc over the last ten years is -92.34%. The current -60.37% ROE has changed -34.62% with respect to the historical average. Over the past ten years (40 quarters), CNTA's ROE was at its highest in in the March 2020 quarter at 0%. The ROE was at its lowest in in the December 2020 quarter at -106.07%.

Quarterly (TTM)
Annual

Average

-92.34%

Median

-63.95%

Minimum

-344.19%

Maximum

0%

Centessa Pharmaceuticals plc (CNTA) ROE by Quarter and Year

Discovering the peaks and valleys of Centessa Pharmaceuticals plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual ROE = 0%

Minimum Annual Increase = -Infinity%

Minimum Annual ROE = -344.19%

Quarterly (TTM)
Annual
YearROEChange
2025-37.49%-36.14%
2024-58.71%-8.19%
2023-63.95%-0.56%
2022-64.31%-17.22%
2021-77.69%-77.43%
2020-344.19%-Infinity%

Centessa Pharmaceuticals plc (CNTA) Average ROE

How has CNTA ROE performed in the past?

The current ROE of Centessa Pharmaceuticals plc (CNTA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-53.39%

5-year avg

-60.43%

10-year avg

-92.34%

Centessa Pharmaceuticals plc (CNTA) ROE vs. Peers

How is CNTA’s ROE compared to its peers?

Centessa Pharmaceuticals plc’s ROE is greater than Apogee Therapeutics, Inc. (-32.64%), greater than Xenon Pharmaceuticals Inc. (-49.23%), greater than Ascentage Pharma Group International (-123.61%), less than Ultragenyx Pharmaceutical Inc. (1.57%), greater than Celcuity Inc. (-244.61%), greater than Zai Lab Limited (-24.29%), greater than CG Oncology, Inc. Common stock (-23.33%), less than Soleno Therapeutics, Inc. (22.86%), greater than Legend Biotech Corporation (-24.91%), greater than Dyne Therapeutics, Inc. (-58.28%),

Build a custom stock screener for Centessa Pharmaceuticals plc (CNTA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Centessa Pharmaceuticals plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Centessa Pharmaceuticals plc (CNTA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Centessa Pharmaceuticals plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Centessa Pharmaceuticals plc's ROE?

How is the ROE calculated for Centessa Pharmaceuticals plc (CNTA)?

What is the highest ROE for Centessa Pharmaceuticals plc (CNTA)?

What is the 3-year average ROE for Centessa Pharmaceuticals plc (CNTA)?

What is the 5-year average ROE for Centessa Pharmaceuticals plc (CNTA)?

How does the current ROE for Centessa Pharmaceuticals plc (CNTA) compare to its historical average?